Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 174
Filter
2.
Cuad. psicol. deporte ; 22(2): 221-235, may. - ago. 2022. tab
Article in English | IBECS | ID: ibc-209130

ABSTRACT

Esta investigación pretende conocer las barreras percibidas, así como posibles variables predictoras, en personas que practican actividad física en centros fitness que se encontraban confinadas en el hogar porla pandemia de COVID-19. La muestra estuvo conformada por 8.087 practicantes de actividad física. Se administró un cuestionario en línea por correo electrónico. Se realizó un análisis descriptivo de las barreras percibidas y un análisis de regresión logística para determinar posibles variables predictoras. Las barreras percibidas más importantes fueron el precio y la suerte de la seguridad. La edad, el sexo, la frecuencia de práctica física vigorosa y la observación de las recomendaciones de la OMS serían las variables predictoras en mayor medida de las barreras percibidas. Los resultados son relevantes para que las organizaciones deportivas planifiquen su oferta de servicios después del confinamiento. (AU)


This research intends to know the perceived barriers, as well as their predictor variables, in people who practice Physical Activity in fitness centers and were home confined due to the COVID-19 pandemic. The sample was conformed of 8,087 physical activity practitioners. An online questionnaire was administered by email. A descriptive analysis of the perceived barriers was done, and logistic regression analysis to determine possible predictor variables. The most important perceived barriers were price and a lack of safety. Age, gender, the vigorous physical practice frequency and the observation of the WHO recommendations would be the predictor variables to a larger extend for the perceived barriers. The results arerelevant for sport organizations to plan their services offer post lockdown. (AU)


Esta pesquisa tem como objetivo conhecer as barreiras percebidas, bem como possíveis variáveis preditivas, em pessoas que praticam atividade física em academias de ginástica que ficaram confinadas em casa pela pandemia do COVID-19. A amostra foi composta por 8.087 praticantes de atividade física. Um questionário online foi administrado pore-mail. Uma análise descritiva das barreiras percebidas e uma análise de regressão logística foram realizadas para determinar possíveis variáveis preditoras. As barreiras percebidas mais importantes foram o preço e a sorte na segurança. Idade, sexo, frequência de prática física vigorosa e observância das recomendações da OMS seriam as variáveis preditoras em maior extensão das barreiras percebidas. Os resultados são relevantes para que as organizações esportivas planejem sua oferta de serviços após o confinamento. (AU)


Subject(s)
Humans , Male , Female , Adolescent , Young Adult , Adult , Middle Aged , Aged , Aged, 80 and over , Pandemics , Coronavirus Infections/epidemiology , Motor Activity , Fitness Centers , Exercise , Spain , Surveys and Questionnaires
12.
Clin Exp Dermatol ; 45(5): 544-548, 2020 Jul.
Article in English | MEDLINE | ID: mdl-31729068

ABSTRACT

BACKGROUND: Mycetoma is recognized as a neglected tropical disease and there are still therapeutic challenges, especially in cases recalcitrant to standard therapy or with high risk of dissemination. Subcultures have been used previously to decrease the virulence of human pathogens. Previous reports have demonstrated that after carrying out 200 subcultures of Nocardia brasiliensis, a decrease in virulence was observed. AIM: To evaluate the effect of attenuated N. brasiliensis strains on the development of lesions in an established mycetoma infection. METHODS: Female 8-12-week-old BALB/c mice were injected with N. brasiliensis suspension to establish a mycetoma. Sixty mice were selected and divided into three groups: two of these groups were inoculated in the dorsum with N. brasiliensis subcultured 200 and 400 times, respectively, while the third group served as control. The thickness of each lesion was measured with calipers every week for 12 weeks. RESULTS: After 12 weeks, we observed that inoculation of 1 × 105 colony-forming units of attenuated N. brasiliensis strains was able to modify the natural history of the infection, with a decrease in the size of the lesions, particularly with P400, compared with the control group (P < 0.01). CONCLUSION: In this experimental evaluation of an immunomodulatory therapy with attenuated N. brasiliensis strains in a murine model, there was a greater stability in the size of the lesion over time in BALB/c mice inoculated with the P400 strain. This treatment could open the possibility of using the attenuated strain as immunomodulatory therapy in patients recalcitrant to standard therapy, with high risk of dissemination or who develop drug-related adverse effects.


Subject(s)
Immunomodulation , Mycetoma/therapy , Nocardia/pathogenicity , Animals , Disease Models, Animal , Female , Mice , Mice, Inbred BALB C , Mycetoma/immunology , Mycetoma/microbiology , Virulence
15.
J Parasitol ; 104(5): 574-575, 2018 10.
Article in English | MEDLINE | ID: mdl-30019983

ABSTRACT

We provide the first report of Acanthocephala ( Prosthenorchis elegans) in Mexican non-human primates. There has been no known treatment against this parasite except for surgical removal, and this has been relatively ineffective because of the small juveniles. We report the presence of P. elegans in a captive breeding colony of squirrel monkeys ( Saimiri sciureus) in Mexico, and we describe a successful treatment protocol. Treatment involved 2 steps: oral administration of the drugs loperamide chlorhydrate (0.5 mg/0.9 kg/3 days) and niclosamide (0.2 mg/0.9 kg/3 days) followed by surgical removal of adult worms from the intestine. Fecal examination during treatment revealed live adults but no living juveniles and no eggs. Surgery after 1 wk of treatment revealed the presence of adults and an absence of juvenile parasites. All adults were physically extracted during the surgery. All subjects recovered from surgery within 1 wk.


Subject(s)
Acanthocephala , Helminthiasis, Animal/therapy , Monkey Diseases/parasitology , Monkey Diseases/therapy , Saimiri/parasitology , Animals , Anthelmintics/therapeutic use , Cockroaches/parasitology , Disease Outbreaks/veterinary , Drug Therapy, Combination/veterinary , Feces/parasitology , Feeding Behavior , Female , Helminthiasis, Animal/epidemiology , Helminthiasis, Animal/parasitology , Intestinal Diseases, Parasitic/epidemiology , Intestinal Diseases, Parasitic/parasitology , Intestinal Diseases, Parasitic/therapy , Intestinal Diseases, Parasitic/veterinary , Intestinal Mucosa/parasitology , Intestinal Mucosa/surgery , Loperamide/therapeutic use , Male , Mexico/epidemiology , Monkey Diseases/epidemiology , Neoptera/parasitology , Niclosamide/therapeutic use
16.
Rev Neurol ; 66(10): 344-352, 2018 May 16.
Article in Spanish | MEDLINE | ID: mdl-29749595

ABSTRACT

INTRODUCTION: Virtual reality technology was first used in the treatment of psychological disorders in 1994. Since then, its application has aroused the interest of clinicians and researchers, and it has become a potential tool for use in psychological evaluation and neurorehabilitation. AIM: To review the different studies that have been published on the treatment of dementias in which virtual reality has been used, with the aim of evaluating its efficacy. DEVELOPMENT: A search was conducted over the last 10 years (2007-2017) in different databases (PubMed, PsycINFO and Dialnet), as well as in Google Scholar. Few studies were found and, judging by the results that were obtained, they cannot be said to be conclusive, although they do offer certain evidence suggesting that virtual reality is a promising field for intervention in persons with dementia. CONCLUSIONS: Virtual reality is a growing and very promising area for psychological intervention in general, and more particularly for the treatment of dementia. It seems to enjoy a very favourable acceptance among persons suffering from dementia. Nevertheless, it is important to understand the new technologies as a tool rather than as a substitute for the therapist. Likewise, there is a need for more rigorous and systematic research that determines the efficacy of this kind of intervention.


TITLE: Realidad virtual y demencia.Introduccion. La utilizacion de la tecnologia de realidad virtual para el tratamiento de trastornos psicologicos se llevo a cabo por primera vez en 1994. Desde entonces, su uso ha despertado el interes de clinicos e investigadores y se ha convertido en una potencial herramienta destinada a la evaluacion y neurorrehabilitacion psicologicas. Objetivo. Revisar las diferentes investigaciones existentes para el tratamiento de las demencias en las que se ha utilizado realidad virtual, con la finalidad de evaluar su eficacia. Desarrollo. Se ha realizado una busqueda de los ultimos 10 años (2007-2017) en diferentes bases de datos (PubMed, PsycINFO y Dialnet), y tambien en Google Scholar. Las investigaciones encontradas son escasas y, por los resultados obtenidos, no puede decirse que sean concluyentes, si bien aportan ciertas evidencias que sugieren que la realidad virtual es un campo prometedor para la intervencion en las personas con demencia. Conclusiones. La realidad virtual es un area en crecimiento y muy prometedora para la intervencion psicologica en general, y para el tratamiento de la demencia en particular. Su acogida parece muy favorable entre las personas que padecen demencia. No obstante, es importante entender las nuevas tecnologias como una herramienta mas que no sustituye al terapeuta. Asimismo, se advierte de la necesidad de mas investigaciones rigurosas y sistematicas que determinen la eficacia de este tipo de intervenciones.


Subject(s)
Dementia/therapy , Therapy, Computer-Assisted , Virtual Reality , Aged , Aged, 80 and over , Cognitive Dysfunction/therapy , Dementia/rehabilitation , Humans , Memory Disorders/rehabilitation , Memory Disorders/therapy , Neuronal Plasticity , Psychomotor Performance , Treatment Outcome
17.
Rev Gastroenterol Mex (Engl Ed) ; 83(1): 25-30, 2018.
Article in English, Spanish | MEDLINE | ID: mdl-28551084

ABSTRACT

INTRODUCTION: The prevalence of Barrett's esophagus has been calculated at between 1.3 and 1.6%. There is little information with respect to this in Mexico. AIM: To determine the frequency and characteristics of Barrett's esophagus in patients that underwent endoscopy at a national referral center, within a 10-year time frame. MATERIAL AND METHODS: The databases of the pathology and gastrointestinal endoscopy departments of the Instituto Nacional de Ciencias Médicas y Nutrición "Salvador Zubirán" were analyzed, covering the period of January 2002 to December 2012. Patients with a histologic diagnosis of Barrett's esophagus were included. The variables of age, sex, the presence of dysplasia/esophageal adenocarcinoma, Barrett's esophagus length, and follow-up were analyzed. RESULTS: Of 43,639 upper gastrointestinal endoscopies performed, 420 revealed Barrett's esophagus, corresponding to a frequency of 9.6 patients for every 1,000 endoscopies. Of those patients, 66.9% (n=281) were men, mean patient age±SD was 57.2±15.3 years, 223 patients (53%) presented with long-segment Barrett's esophagus, and 197 (47%) with short-segment Barrett's esophagus. Dysplasia was not present in 339 patients (80.7%). Eighty-one (19.3%) patients had some grade of dysplasia or cancer: 48/420 (11.42%) presented with low-grade dysplasia, 20/420 (4.76%) with high-grade dysplasia, and 13/420 (3.1%) were diagnosed with esophageal cancer arising from Barrett's esophagus. Mean follow-up time was 5.6 years. CONCLUSIONS: The frequency of Barrett's esophagus was 9.6 cases for every 1,000 upper gastrointestinal endoscopies performed. Dysplasia was not documented in the majority of the patients with Barrett's esophagus and they had no histopathologic changes during follow-up. A total of 19.3% of the patients presented with dysplasia or cancer.


Subject(s)
Barrett Esophagus/diagnosis , Barrett Esophagus/epidemiology , Adult , Aged , Barrett Esophagus/pathology , Barrett Esophagus/therapy , Disease Progression , Female , Follow-Up Studies , Humans , Male , Mexico/epidemiology , Middle Aged , Prevalence , Retrospective Studies , Tertiary Care Centers
18.
Sci Total Environ ; 599-600: 2121-2134, 2017 Dec 01.
Article in English | MEDLINE | ID: mdl-28575928

ABSTRACT

The most destructive wildfire experienced in Spain since 2004 occurred close to Valencia in summer 2012. A total of 48.500ha were affected by two wildfires, which were mostly active during 29-30 June. The fresh smoke plume was detected at the Burjassot measurement station simultaneously to a severe dust episode. We propose an empirical method to evaluate the dust and smoke mixing and its impact on the microphysical and optical properties. For this, we combine direct-sun measurements with a Cimel CE-318 sun-photometer with an inversion methodology, and the Mie theory to derive the column-integrated size distribution, single scattering albedo (SSA) and asymmetry parameter (g). The mixing of dust and smoke greatly increased the aerosol load and modified the background aerosol properties. Mineral dust increased the aerosol optical depth (AOD) up to 1, while the smoke plume caused an extreme AOD peak of 8. The size distribution of the mixture was bimodal, with a fine and coarse modes dominated by the smoke particles and mineral dust, respectively. The SSA and g for the dust-smoke mixture show a marked sensitivity on the smoke mixing-ratio, mainly at longer wavelengths. Mineral dust and smoke share a similar SSA at 440nm (~0.90), but with opposite spectral dependency. A small dust contribution to the total AOD substantially affects the SSA of the mixture, and also SSA at 1020nm increases from 0.87 to 0.95. This leads to a different spectral behaviour of SSA that changes from positive (smoke plume) to negative (dust), depending on the dust and smoke mixing-ratio.

19.
J Photochem Photobiol B ; 163: 290-5, 2016 Oct.
Article in English | MEDLINE | ID: mdl-27607308

ABSTRACT

Measurements of ultraviolet erythemal radiation (UVER) made during two years at three sites located at altitudes over 1000ma.s.l. in Northwestern Argentina (Salta, San Carlos, and El Rosal) have been used to estimate and analyze the UV Index (UVI) and the cumulative doses at these locations. For the UVER irradiance, data of January (maximum values) and June (minimum values) have been analyzed as representative of the year for all locations. The UVI reaches extreme (>11) values in >20% of the analyzed days in Salta (1190ma.s.l.), while these are reached in San Carlos (1611ma.s.l.) and El Rosal (3355ma.s.l.) in >40% of the analyzed days. Finally, the cumulative doses over an average year have also been studied for each location. The doses received during austral summer and autumn are of the same order, and represent one third of the annual dose, while the doses received during austral winter and spring represent one sixth of the annual dose approximately.


Subject(s)
Altitude , Radiation Monitoring , Ultraviolet Rays , Argentina , Radiation Dosage
20.
Med Intensiva ; 40(5): 280-8, 2016.
Article in English, Spanish | MEDLINE | ID: mdl-26777736

ABSTRACT

OBJECTIVE: To evaluate the use and effectiveness of a routine invasive strategy (RIS) in patients with acute coronary syndrome without persistent ST-segment elevation with renal dysfunction in the real world scenario. METHODS: A retrospective cohort study based on the ARIAM-SEMICYUC Registry (2011-2014) was carried out. Renal dysfunction was defined as GFR (Cockroft-Gault)<60ml/min (moderate dysfunction) or<30ml/min (severe dysfunction). Patients in which early angiography (<72h) was performed due to cardiogenic shock or recurrent myocardial ischemia were excluded. The primary endpoint was hospital mortality. Confounding factors were controlled using propensity score analysis. RESULTS: A total of 4,279 patients were analyzed, of which 26% had moderate renal dysfunction and 5% severe dysfunction. Patients with renal dysfunction had greater severity and comorbidity, higher hospital mortality (8.6 vs. 1.8%), and lesser use of the RIS (40 vs. 52%). The adjusted OR for mortality in patients without/with renal dysfunction were 0.38 (95% confidence interval [95%CI] 0.17 to 0.81) and 0.52 (95%CI 0.32 to 0.87), respectively (interaction P-value=.4779). The impact (adjusted risk difference) of RIS was higher in the group with renal dysfunction (-5.1%, 95%CI -8.1 to -2.1 vs. -1.6%, 95%CI -2.6 to -0.6; interaction P-value=.0335). No significant interaction was detected for the other endpoints considered (ICU mortality, 30-day mortality, myocardial infarction, acute renal failure or moderate/severe bleeding). CONCLUSIONS: The results suggest that the effectiveness of IRS is similar in patients with normal or abnormal renal function, and alert to the under-utilization of this strategy in such patients.


Subject(s)
Acute Coronary Syndrome/therapy , Coronary Angiography , Kidney Diseases/complications , Myocardial Revascularization , Non-ST Elevated Myocardial Infarction/therapy , Acute Coronary Syndrome/complications , Acute Coronary Syndrome/diagnostic imaging , Aged , Aged, 80 and over , Female , Hospital Mortality , Humans , Intensive Care Units/statistics & numerical data , Male , Middle Aged , Non-ST Elevated Myocardial Infarction/complications , Non-ST Elevated Myocardial Infarction/diagnostic imaging , Propensity Score , Recurrence , Registries , Retrospective Studies , Risk , Severity of Illness Index , Spain/epidemiology , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...